Inhibition of osteoclastogenic differentiation by Ikarisoside A in RAW 264.7 cells via JNK and NF-ΚB signaling pathways

European Journal of Pharmacology

Volumn 636, Issue 1-3, 2010, Pages 28-35

  Choi, Hwa Jung ^a   Park, Young Ran ^a   Nepal, Manoj ^a   Choi, Bo Yun ^a   Cho, Nam Pyo ^a   Choi, Seoung Hwan ^a   Heo, Soo Rye ^a   Kim, Hyung Sup ^a   Yang, Moon Sik ^a   Soh, Yunjo ^a  

^a Chonbuk National University   (South Korea)

Author keywords

Bone; Ikarisoside A; Osteoclast; Osteoclastogenesis; RANKL; RAW 264.7; TRAP

Indexed keywords

ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; CALCIUM PHOSPHATE; CATHEPSIN K; FLAVONOID; GELATINASE B; IKARISOSIDE A; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NUCLEAR FACTOR; NUCLEAR FACTOR OF ACTIVATED T CELLS C1; OSTEOCLAST DIFFERENTIATION FACTOR; PROTEIN C FOS; PROTEIN KINASE B; STRESS ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL CELL CULTURE; ARTICLE; BERBERIDACEAE; CELL LINE; CELL STRAIN RAW 264.7; CONTROLLED STUDY; DRUG EFFECT; DRUG ISOLATION; EPIDEMIUM KOREANUM; GENETIC TRANSFECTION; IMMUNOBLOTTING; INHIBITION KINETICS; MACROPHAGE; MONOCYTE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OSTEOCLASTOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

ANIMALS; BONE RESORPTION; CELL DIFFERENTIATION; CELL LINE; ENZYME ACTIVATION; FLAVONOIDS; GENE EXPRESSION REGULATION; GLYCOSIDES; MAP KINASE KINASE 4; MAP KINASE SIGNALING SYSTEM; MICE; NF-KAPPA B; NFATC TRANSCRIPTION FACTORS; OSTEOCLASTS; PROTO-ONCOGENE PROTEINS C-FOS; RANK LIGAND;

EID: 77952672479     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2010.03.023     Document Type: Article

References (36)

1. Anandarajah A.P., Schwarz E.M. Anti-RANKL therapy for inflammatory bone disorders: mechanisms and potential clinical applications. J. Cell. Biochem. 2006, 97:226-232.
2. Anusaksathien O., Laplace C., Li X., Ren Y., Peng L., Goldring S.R., Galson D.L. Tissue-specific and ubiquitous promoters direct the expression of alternatively spliced transcripts from the calcitonin receptor gene. J. Biol. Chem. 2001, 276:22663-22674.
3. Chang E.J., Kim H.J., Ha J., Kim H.J., Ryu J., Park K.H., Kim U.H., Lee Z.H., Kim H.M., Fisher D.E., Kim H.H. Hyaluronan inhibits osteoclast differentiation via Toll-like receptor 4. J. Cell Sci. 2007, 120:166-176.
4. Choi H.J., Eun J.S., Park Y.R., Kim D.K., Li R., Moon W.S., Park J.M., Kim H.S., Cho N.P., Cho S.D., Soh Y. Ikarisoside A inhibits inducible nitric oxide synthase in lipopolysaccharide-stimulated RAW 264.7 cells via p38 kinase and nuclear factor-kappaB signaling pathways. Eur. J. Pharmacol. 2008, 601:171-178.
5. Choi H.J., Eun J.S., Kim D.K., Li R.H., Shin T.Y., Park H., Cho N.P., Soh Y. Icariside II from Epimedium koreanum inhibits hypoxia-inducible factor-1alpha in human osteosarcoma cells. Eur. J. Pharmacol. 2008, 579:58-65.
6. Coon D., Gulati A., Cowan C., He J. The role of cyclooxygenase-2 (COX-2) in inflammatory bone resorption. J. Endod. 2007, 33:432-436.
7. Franzoso G., Carlson L., Xing L., Poljak L., Shores E.W., Brown K.D., Leonardi A., Tran T., Boyce B.F., Siebenlist U. Requirement for NF-kappaB in osteoclast and B-cell development. Genes Dev. 1997, 11:3482-3496.
8. Han K.Y., Yang D., Chang E.J., Lee Y., Huang H., Sung S.H., Lee Z.H., Kim Y.C., Kim H.H. Inhibition of osteoclast differentiation and bone resorption by sauchinone. Biochem. Pharmacol. 2007, 74:911-923.
9. Jimi E., Aoki K., Saito H., D'Acquisto F., May M.J., Nakamura I., Sudo T., Kojima T., Okamoto F., Fukushima H., Okabe K., Ohya K., Ghosh S. Selective inhibition of NF-kappa B blocks osteoclastogenesis and prevents inflammatory bone destruction in vivo. Nature Med. 2004, 10:617-624.
10. Karsenty G., Wagner E.F. Reaching a genetic and molecular understanding of skeletal development. Dev. Cell 2002, 2:389-406.
11. Kobayashi N., Kadono Y., Naito A., Matsumoto K., Yamamoto T., Tanaka S., Inoue J. Segregation of TRAF6-mediated signaling pathways clarifies its role in osteoclastogenesis. EMBO J. 2001, 20:1271-1280.
12. Kotake S., Udagawa N., Takahashi N., Matsuzaki K., Itoh K., Ishiyama S., Saito S., Inoue K., Kamatani N., Gillespie M.T., Martin T.J., Suda T. IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis. J. Clin. Invest. 1999, 103:1345-1352.
13. Kuroda M., Mimaki Y., Sashida Y., Umegaki E., Yamazaki M., Chiba K., Mohri T., Kitahara M., Yasuda A., Naoi N., Xu Z.W., Li M.R. Flavonol glycosides from Epimedium sagittatum and their neurite outgrowth activity on PC12h cells. Planta Med. 2000, 66:575-577.
14. Lee S.E., Woo K.M., Kim S.Y., Kim H.M., Kwack K., Lee Z.H., Kim H.H. The phosphatidylinositol 3-kinase, p38, and extracellular signal-regulated kinase pathways are involved in osteoclast differentiation. Bone 2002, 30:71-77.
15. Li W.K., Zhang R.Y., Xiao P.G. Flavonoids from Epimedium wanshanense. Phytochemistry 1996, 43:527-530.
16. Li W.K., Xiao P.G., Pan J.Q. Complete assignment of 1H and 13C NMR spectra of Ikarisoside A and epimedoside C. Magn. Reson. Chem. 1998, 36:303-304.
17. Luo J.L., Kamata H., Karin M. IKK/NF-kappaB signaling: balancing life and death-a new approach to cancer therapy. J. Clin. Invest. 2005, 115:2625-2632.
18. Mino T., Sugiyama E., Taki H., Kuroda A., Yamashita N., Maruyama M., Kobayashi M. Interleukin-1alpha and tumor necrosis factor alpha synergistically stimulate prostaglandin E2-dependent production of interleukin-11 in rheumatoid synovial fibroblasts. Arthritis Rheum. 1998, 41:2004-2013.
19. Miyazaki T., Katagiri H., Kanegae Y., Takayanagi H., Sawada Y., Yamamoto A., Pando M.P., Asano T., Verma I.M., Oda H., Nakamura K., Tanaka S. Reciprocal role of ERK and NF-kappaB pathways in survival and activation of osteoclasts. J. Cell Biol. 2000, 148:333-342.
20. Mohamed S.G., Sugiyama E., Shinoda K., Taki H., Hounoki H., Abdel-Aziz H.O., Maruyama M., Kobayashi M., Ogawa H., Miyahara T. Interleukin-10 inhibits RANKL-mediated expression of NFATc1 in part via suppression of c-Fos and c-Jun in RAW264.7 cells and mouse bone marrow cells. Bone 2007, 41:592-602.
21. Motyckova G., Weilbaecher K.N., Horstmann M., Rieman D.J., Fisher D.Z., Fisher D.E. Linking osteopetrosis and pycnodysostosis: regulation of cathepsin K expression by the microphthalmia transcription factor family. Proc. Natl. Acad. Sci. 2001, 98:5798-5803.
22. Mozar A., Haren N., Chasseraud M., Louvet L., Maziere C., Wattel A., Mentaverri R., Morliere P., Kamel S., Brazier M., Maziere J.C., Massy Z.A. High extracellular inorganic phosphate concentration inhibits RANK-RANKL signaling in osteoclast-like cells. J. Cell. Physiol. 2008, 215:47-54.
23. Park C.K., Kim H.J., Kwak H.B., Lee T.H., Bang M.H., Kim C.M., Lee Y., Chung D.K., Baek N.I., Kim J., Lee Z.H., Kim H.H. Inhibitory effects of Stewartia koreana on osteoclast differentiation and bone resorption. Int. Immunopharmacol. 2007, 7:1507-1516.
24. Reddy S.V., Hundley J.E., Windle J.J., Alcantara O., Linn R., Leach R.J., Boldt D.H., Roodman G.D. Characterization of the mouse tartrate-resistant acid phosphatase (TRAP) gene promoter. J. Bone Miner. Res. 1995, 10:601-606.
25. Soh Y., Song B.J., Jeng J., Kallarakal A.T. Critical role of arg433 in rat transketolase activity as probed by site-directed mutagenesis. Biochem. J. 1998, 333(Pt 2):367-372.
26. Soh Y., Jeong K.S., Lee I.J., Bae M.A., Kim Y.C., Song B.J. Selective activation of the c-Jun N-terminal protein kinase pathway during 4-hydroxynonenal-induced apoptosis of PC12 cells. Mol. Pharmacol. 2000, 58:535-541.
27. Soh Y., Shin M.H., Lee J.S., Jang J.H., Kim O.H., Kang H., Surh Y.J. Oxidative DNA damage and glioma cell death induced by tetrahydropapaveroline. Mutat. Res. 2003, 544:129-142.
28. Stern P.H. Antiresorptive agents and osteoclast apoptosis. J. Cell. Biochem. 2007, 101:1087-1096.
29. Takayanagi H., Kim S., Koga T., Nishina H., Isshiki M., Yoshida H., Saiura A., Isobe M., Yokochi T., Inoue J., Wagner E.F., Mak T.W., Kodama T., Taniguchi T. Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts. Dev. Cell 2002, 3:889-901.
30. Theill L.E., Boyle W.J., Penninger J.M. RANK-L and RANK: T cells, bone loss, and mammalian evolution. Annu. Rev. Immunol. 2002, 20:795-823.
31. Vaira S., Johnson T., Hirbe A.C., Alhawagri M., Anwisye I., Sammut B., O'Neal J., Zou W., Weilbaecher K.N., Faccio R., Novack D.V. RelB is the NF-kappaB subunit downstream of NIK responsible for osteoclast differentiation. Proc. Natl. Acad. Sci. U.S.A. 1998, 105(10):3897-38902.
32. Viatour P., Merville M.P., Bours V., Chariot A. Phosphorylation of NF-kappaB and IkappaB proteins: implications in cancer and inflammation. Trends Biochem. Sci. 2005, 30:43-52.
33. Wong B.R., Besser D., Kim N., Arron J.R., Vologodskaia M., Hanafusa H., Choi Y. TRANCE, a TNF family member, activates Akt/PKB through a signaling complex involving TRAF6 and c-Src. Mol. Cell 1999, 4:1041-1049.
34. Yamashita T., Yao Z., Li F., Zhang Q., Badell I.R., Schwarz E.M., Takeshita S., Wagner E.F., Noda M., Matsuo K., Xing L., Boyce B.F. NF-kappaB p50 and p52 regulate receptor activator of NF-kappaB ligand (RANKL) and tumor necrosis factor-induced osteoclast precursor differentiation by activating c-Fos and NFATc1. J. Biol. Chem. 2007, 282:18245-18253.
35. Yoshida H., Hayashi S., Kunisada T., Ogawa M., Nishikawa S., Okamura H., Sudo T., Shultz L.D., Nishikawa S. The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene. Nature 1990, 345:442-444.
36. Zhou B., Cron R.Q., Wu B., Genin A., Wang Z., Liu S., Robson P., Baldwin H.S. Regulation of the murine Nfatc1 gene by NFATc2. J. Biol. Chem. 2002, 277:10704-10711.